Scarica l'app Stockscreener
5.28
5.39%
0.27
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SGHT Giù?
Forum
Previsione
Precedente Chiudi:
$5.01
Aprire:
$5.12
Volume 24 ore:
281.61K
Relative Volume:
1.11
Capitalizzazione di mercato:
$287.28M
Reddito:
$79.55M
Utile/perdita netta:
$-37.25M
Rapporto P/E:
-7.4851
EPS:
-0.7054
Flusso di cassa netto:
$-25.40M
1 W Prestazione:
+10.23%
1M Prestazione:
+8.64%
6M Prestazione:
-36.08%
1 anno Prestazione:
+23.65%
Intervallo 1D:
$5.07
$5.33
Intervallo di 1 settimana:
$4.87
$5.33
Portata 52W:
$3.11
$9.2362
Sight Sciences Inc Stock (SGHT) Company Profile
Nome
Sight Sciences Inc
Settore
Industria
Telefono
(415) 889-0550
Indirizzo
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
5.28 | 287.28M | 79.55M | -37.25M | -25.40M | -0.7054 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-05 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-08-08 | Aggiornamento | Lake Street | Hold → Buy |
| 2024-12-06 | Iniziato | UBS | Buy |
| 2024-11-04 | Downgrade | Lake Street | Buy → Hold |
| 2024-08-21 | Iniziato | Lake Street | Buy |
| 2023-09-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-09-12 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | Downgrade | Citigroup | Buy → Neutral |
| 2023-01-06 | Aggiornamento | Stifel | Hold → Buy |
| 2022-10-04 | Iniziato | Needham | Hold |
| 2022-07-26 | Iniziato | Stifel | Hold |
| 2022-02-03 | Iniziato | William Blair | Outperform |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
Mostra tutto
Sight Sciences Inc Borsa (SGHT) Ultime notizie
Sight Sciences Inc (SGHT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Sight Sciences Inc (SGHT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Sight Sciences Inc (SGHT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sight Sciences Inc (SGHT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Sight Sciences Inc (SGHT) Institutional Confidence - TradingKey
Sight Sciences Inc (SGHT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Sight Sciences Inc (SGHT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sight Sciences Inc (SGHT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sight Sciences Inc (SGHT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sight Sciences director Encrantz buys $68,793 in company stock By Investing.com - Investing.com Nigeria
Sight Sciences director Encrantz buys $68,793 in company stock - Investing.com
Sight Sciences (SGHT) director boosts direct stake with 14,100-share buy - Stock Titan
Sight Sciences | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Discover 3 Promising Penny Stocks With Market Caps Over $20M - Sahm
Number of shareholders of Sight Sciences, Inc. – NASDAQ:SGHT - TradingView
Sight Sciences Shareholders Reelect Directors, Ratify Auditor - The Globe and Mail
Sight Sciences (SGHT) Dips 3.26% as Medical Device Stock Tests Key SupportLast Point Resistance - newsline.com
Sight Sciences (SGHT) grants RSU award to board director - Stock Titan
Sight Sciences (SGHT) director awarded 28,261 RSUs worth about $130,000 - Stock Titan
Sight Sciences (SGHT) grants $130K in RSUs to board director - Stock Titan
Sight Sciences (SGHT) director Donald Zurbay awarded 28,261 RSUs valued at about $130,000 - Stock Titan
Sight Sciences (NASDAQ: SGHT) director receives 28,261 RSUs grant - Stock Titan
Sight Sciences (NASDAQ: SGHT) reports 2026 shareholder meeting voting results - Stock Titan
Sight Sciences (SGHT) Q1 earnings: How key metrics compare to Wall Street estimates - MSN
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Beats Revenue Estimates - Eastern Progress
Sight Sciences Inc. (SGHT) Nears Key Support After 3.95% DeclineTrading Ideas - The Legal Advocate
Sight Sciences Inc stock (US8177721062): Nasdaq-listed eye-care player sees muted trading ahead of Q - AD HOC NEWS
Sight Sciences Inc. (SGHT) Nears Support as Shares Edge LowerMoving Average Crossovers - newsline.com
SGHT Maintained by Citigroup -- Price Target Raised to $5.15 - GuruFocus
Sight Sciences Drops in Pre-Market Trade as Investors Watch SGHT Growth - Bez Kabli
Sight Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Bauerlein Alison - Moomoo
Sight Sciences wins $34M patent ruling against Alcon - MSN
Sight Sciences Inc. (SGHT) Q1 2026 Earnings: EPS Misses Estimates as Operating Losses WidenEarnings Growth Analysis - Newser
Sight Sciences Inc. (SGHT) Q1 2026 Earnings: Wider-Than-Expected Loss Drags Stock Down Over 2%Tax Rate Impact - Newser
Sight Sciences stock (US8177721062): eye-care specialist in focus after latest business update - AD HOC NEWS
Sight Sciences (SGHT) Q1 2026 Results Disappoint — Multiple Headwinds CitedSocial Buzz Stocks - Newser
Sight Sciences (SGHT) Fell -0.64% — Is a Recovery Ahead? 2026-05-20Sector Neutral Pair - Newser
Sight Sciences (SGHT) COO sells 12,728 shares to cover RSU tax obligations - Stock Titan
Sight Sciences stock (US8177721062): eye-care specialist in focus after recent earnings and FDA upda - AD HOC NEWS
Sight Sciences appoints Ali Bauerlein as COO and Jim Rodberg as CFO - MSN
Sight Sciences signals $83M-$89M 2026 revenue outlook while targeting $6M-$8M dry eye sales - MSN
sight sciences, inc. Earnings dates - RTTNews
Affiliate plans sale of 12,728 SGHT shares (NASDAQ: SGHT) via Fidelity - Stock Titan
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
TradingKey - TradingKey
Sight Sciences (SGHT) Climbs +2.86% — Resistance at $5.29 in Focus 2026-05-14Price Target - newsline.com
SGHT (Sight Sciences) posts wider-than-expected loss as earnings miss forecasts by 42%, shares dip.Wall Street Picks - Newser
Sight Sciences (SGHT) Q1 Loss Of US$0.24 EPS Tests Margin Improvement Narrative - Sahm
Sight Sciences Inc Azioni (SGHT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):